The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harding, C. V.
Right arrow Articles by Siman, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harding, C. V.
Right arrow Articles by Siman, R.

The Journal of Immunology, Vol 155, Issue 4 1767-1775, Copyright © 1995 by American Association of Immunologists


ARTICLES

Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway

CV Harding, J France, R Song, JM Farah, S Chatterjee, M Iqbal and R Siman
Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.

Class I MHC (MHC-I) molecules present peptides derived from Ag that are processed in the cytosol. The proteasome is a multicatalytic protease complex that is present in the cytosol and has been implicated in cytosolic Ag processing. Novel dipeptide aldehydes were designed, synthesized, and demonstrated to specifically inhibit the chymotrypsin- like protease activity of isolated proteasomes, but produced relatively little inhibition of cathepsin B, a vacuolar cysteine protease. The inhibitors were membrane permeable and inhibited intracellular cleavage of a membrane-permeable fluorogenic substrate of the chymotrypsin-like proteasome activity. When a model Ag, OVA, was introduced into the cytoplasm of M12.B6 murine B cells by electroporation, the proteasome inhibitors blocked its processing for subsequent presentation by MHC-I molecules. The inhibitors had little effect on class II MHC processing of exogenous Ag. The potencies of different inhibitors for blockade of MHC-I Ag processing correlated directly with their potencies for inhibition of the chymotrypsin-like proteasome activity. In contrast, conventional inhibitors of vacuolar cysteine proteases (e.g., leupeptin and benzyloxycarbonyl-Phe-Ala-CHN2) had little effect on MHC-I processing or the chymotryspin-like activity of isolated proteasomes. These results directly demonstrate that inhibition of proteasome activity blocks MHC-I Ag processing, confirming a role for proteasomes in this pathway. Moreover, they suggest that the chymotrypsin-like activity of the proteasome may be of major importance to the cytosolic processing of at least some Ag.


This article has been cited by other articles:


Home page
J. Immunol.Home page
W. H.D. Hallett, E. Ames, M. Motarjemi, I. Barao, A. Shanker, D. L. Tamang, T. J. Sayers, D. Hudig, and W. J. Murphy
Sensitization of Tumor Cells to NK Cell-Mediated Killing by Proteasome Inhibition
J. Immunol., January 1, 2008; 180(1): 163 - 170.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Ohmura-Hoshino, Y. Matsuki, M. Aoki, E. Goto, M. Mito, M. Uematsu, T. Kakiuchi, H. Hotta, and S. Ishido
Inhibition of MHC Class II Expression and Immune Responses by c-MIR
J. Immunol., July 1, 2006; 177(1): 341 - 354.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Mitaksov and D. H. Fremont
Structural Definition of the H-2Kd Peptide-binding Motif
J. Biol. Chem., April 14, 2006; 281(15): 10618 - 10625.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Nam, D. M. Smith, and Q. P. Dou
Tannic Acid Potently Inhibits Tumor Cell Proteasome Activity, Increases p27 and Bax Expression, and Induces G1 Arrest and Apoptosis
Cancer Epidemiol. Biomarkers Prev., October 1, 2001; 10(10): 1083 - 1088.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. S. Potter and C. V. Harding
Neutrophils Process Exogenous Bacteria Via an Alternate Class I MHC Processing Pathway for Presentation of Peptides to T Lymphocytes
J. Immunol., September 1, 2001; 167(5): 2538 - 2546.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Sun, S. Nam, C.-S. Lee, B. Li, D. Coppola, A. D. Hamilton, Q. P. Dou, and S. M. Sebti
CEP1612, a Dipeptidyl Proteasome Inhibitor, Induces p21WAF1 and p27KIP1 Expression and Apoptosis and Inhibits the Growth of the Human Lung Adenocarcinoma A-549 in Nude Mice
Cancer Res., February 1, 2001; 61(4): 1280 - 1284.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
A. Bai, C. J. Aldrich, and J. Forman
Factors Controlling the Trafficking and Processing of a Leader-Derived Peptide Presented by Qa-1
J. Immunol., December 15, 2000; 165(12): 7025 - 7034.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Y. Mo, P. Cascio, K. Lemerise, A. L. Goldberg, and K. Rock
Distinct Proteolytic Processes Generate the C and N Termini of MHC Class I-Binding Peptides
J. Immunol., December 1, 1999; 163(11): 5851 - 5859.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Steiner, A. Capell, B. Pesold, M. Citron, P. M. Kloetzel, D. J. Selkoe, H. Romig, K. Mendla, and C. Haass
Expression of Alzheimer's Disease-associated Presenilin-1 Is Controlled by Proteolytic Degradation and Complex Formation
J. Biol. Chem., November 27, 1998; 273(48): 32322 - 32331.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Beninga, K. L. Rock, and A. L. Goldberg
Interferon-gamma Can Stimulate Post-proteasomal Trimming of the N Terminus of an Antigenic Peptide by Inducing Leucine Aminopeptidase
J. Biol. Chem., July 24, 1998; 273(30): 18734 - 18742.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Cardozo and R. A. Kohanski
Altered Properties of the Branched Chain Amino Acid-preferring Activity Contribute to Increased Cleavages after Branched Chain Residues by the "Immunoproteasome"
J. Biol. Chem., July 3, 1998; 273(27): 16764 - 16770.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M. Benham, M. Gromme, and J. Neefjes
Allelic Differences in the Relationship Between Proteasome Activity and MHC Class I Peptide Loading
J. Immunol., July 1, 1998; 161(1): 83 - 89.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. J. Luckey, G. M. King, J. A. Marto, S. Venketeswaran, B. F. Maier, V. L. Crotzer, T. A. Colella, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard
Proteasomes Can Either Generate or Destroy MHC Class I Epitopes: Evidence for Nonproteasomal Epitope Generation in the Cytosol
J. Immunol., July 1, 1998; 161(1): 112 - 121.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. C. Anton, H. L. Snyder, J. R. Bennink, A. Vinitsky, M. Orlowski, A. Porgador, and J. W. Yewdell
Dissociation of Proteasomal Degradation of Biosynthesized Viral Proteins from Generation of MHC Class I-Associated Antigenic Peptides
J. Immunol., May 15, 1998; 160(10): 4859 - 4868.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. A. M. Sijts, I. Pilip, and E. G. Pamer
The Listeria monocytogenes-secreted p60 Protein Is an N-end Rule Substrate in the Cytosol of Infected Cells. IMPLICATIONS FOR MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I ANTIGEN PROCESSING OF BACTERIAL PROTEINS
J. Biol. Chem., August 1, 1997; 272(31): 19261 - 19268.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
T. W. Tobery and R. F. Siliciano
Targeting of HIV-1 Antigens for Rapid Intracellular Degradation Enhances Cytotoxic T Lymphocyte (CTL) Recognition and the Induction of De Novo CTL Responses In Vivo After Immunization
J. Exp. Med., March 3, 1997; 185(5): 909 - 920.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Komlosh, F. Momburg, T. Weinschenk, N. Emmerich, H. Schild, E. Nadav, I. Shaked, and Y. Reiss
A Role for a Novel Luminal Endoplasmic Reticulum Aminopeptidase in Final Trimming of 26 S Proteasome-generated Major Histocompatability Complex Class I Antigenic Peptides
J. Biol. Chem., August 3, 2001; 276(32): 30050 - 30056.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.